Genome editing of PD-L1 mediated by nucleobase-modified polyamidoamine for cancer immunotherapy
Simeng Wei(Jilin University), Quanshun Li(Jilin University), Xinxin Shao(Shandong University of Technology), Ziling Liu(Jilin University), Yong Liu(Shanghai First People's Hospital), Peng‐Fei Cui(Changzhou University), Boyu Xiong(Jilin University)
Cited by 15
Related Papers
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
|Nature Medicine|2010|395
Antimicrobial peptides towards clinical application: Delivery and formulation
|Advanced Drug Delivery Reviews|2021|263
Repair of Large Articular Osteochondral Defects Using Hybrid Scaffolds and Bone Marrow-Derived Mesenchymal Stem Cells in a Rabbit Model
|Tissue Engineering|2006|186
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer
|JAMA Oncology|2023|165
Developing an alginate/chitosan hybrid fiber scaffold for annulus fibrosus cells
|Journal of Biomedical Materials Research Part A|2007|118